You just read:

Therabron Therapeutics Receives FDA Fast Track Designation for rhCC10 for the Prevention of Chronic Lung Disease Related to Premature Birth

News provided by

Therabron Therapeutics, Inc.

Apr 28, 2016, 14:33 ET